Presenilin-dependent Intramembrane Proteolysis of CD44 Leads to the Liberation of Its Intracellular Domain and the Secretion of an Aβ-like Peptide*
- Sven Lammich‡,
- Masayasu Okochi§,
- Masatoshi Takeda§,
- Christoph Kaether‡,
- Anja Capell‡,
- Ann-Katrin Zimmer‡,
- Dieter Edbauer‡,
- Jochen Walter‡,
- Harald Steiner‡¶ and
- Christian Haass‡¶
- From the ‡Adolf-Butenandt-Institute, Department of Biochemistry, Laboratory for Alzheimer's and Parkinson's Disease Research, Schillerstr. 44; Ludwig-Maximilians-University, 80336 Munich, Germany and the §Department of Post-Genomics and Diseases, Division of Psychiatry and Behavioral Proteomics, Osaka University Graduate School of Medicine, 565-0871 Osaka, Japan
Abstract
Alzheimer's disease (AD)-associated γ-secretase is a presenilin (PS)- dependent proteolytic activity involved in the intramembraneous cleavage of the β-amyloid precursor protein, Notch, LDL receptor-related protein, E-cadherin, and ErbB-4. This cut produces the corresponding intracellular domains (ICD), which are required for nuclear signaling of Notch and probably ErbB-4, the β-amyloid precursor protein, E-cadherin, and the LDL receptor-related protein as well. We have now investigated CD44, a cell surface adhesion molecule, which also undergoes an intramembraneous cleavage to liberate its ICD. We demonstrate that this cleavage requires a PS-dependent γ-secretase activity. A loss-of-function PS1 mutation, a PS1/PS2 knockout, as well as two independent and highly specific γ-secretase inhibitors, abolish this cleavage. Surprisingly, small peptides similar to the amyloid β-peptide (Aβ) are generated by an additional cut in the middle of the transmembrane region of CD44. Like Aβ, these CD44 β-peptides are generated in a PS-dependent manner. These findings therefore suggest a dual intramembraneous cleavage mechanism mediated by PS proteins. The dual cleavage mechanism is required for nuclear signaling as well as removal of remaining transmembrane domains, a general function of PS in membrane protein metabolism.
- Aβ
- amyloid β-peptide
- AD
- Alzheimer's disease
- βAPP
- β-amyloid precursor protein
- AICD
- APP intracellular domain
- CD44-ICD
- CD44 intracellular domain
- CTF
- C-terminal fragment
- DAPT
- N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycinet-butyl ester
- HEK
- human embryonic kidney
- ICD
- intracellular domain
- IDE
- insulin-degrading enzyme
- LRP
- LDL receptor-related protein
- MALDI-TOF MS
- matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry
- NICD
- Notch intracellular domain
- PS
- presenilin
- TMD
- transmembrane domain
- Tricine
- N-[2-hydroxy- 1,1-bis(hydroxymethyl)ethyl]glycine
- Received July 10, 2002.
- Revision received August 29, 2002.
- The American Society for Biochemistry and Molecular Biology, Inc.











